Enhancing Care Study in Patients After CABG
OptiCABG
Enhancing Care in Patients After Coronary Artery Bypass Graft Surgery (CABG): OptiCABG Study
1 other identifier
observational
40,000
1 country
1
Brief Summary
Review the data of patients who underwent coronary artery bypass grafting (CABG) at the National Center for Cardiovascular Disease, Fuwai Hospital from January 2013 to June 2023 including medical history, head CT scan, and postoperative, including 30-day mortality, arrhythmia, cerebrovascular disease and intracerebral haemorrhage, etc. Case-control and retrospective cohort studies were conducted to explore the risk factors associated with early postoperative complications, examine their relationship with postoperative management, explore independent risk factors of compound complications, and build predictive models.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 28, 2024
CompletedFirst Posted
Study publicly available on registry
July 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
July 5, 2024
June 1, 2024
13.5 years
June 28, 2024
June 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
30-day mortality
The proportion of patients who die within 30 days of being admitted to the hospital.
30 days
Secondary Outcomes (2)
post-operative atrial fibrillation
Around the second postoperative day.
MACE
Around the second postoperative day.
Eligibility Criteria
Patients who accepted coronary artery bypass graft and met the eligibility criteria are enrolled for this study.
You may qualify if:
- patients accepted CABG enrolled from January 2013 to June 2023
You may not qualify if:
- patients discharged within 72 hours of admission
- patients with an admission diagnosis of atrial fibrillation
- patients underwent CABG as emergency surgery
- patients underwent concurrent surgical treatments
- patients with repeat admissions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Structral Heart Disease Center, Fuwai Hospital
Beijing, Beijing Municipality, China
Study Officials
- PRINCIPAL INVESTIGATOR
Xiangbin Pan, MD
Chinese Academy of Medical Sciences, Fuwai Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 28, 2024
First Posted
July 5, 2024
Study Start
January 1, 2013
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
July 5, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share